Akerna Exercises Option to Acquire Remaining Stake in solo sciences inc.

Akerna is planning to acquire the remaining 20% of solo sciences inc. Akerna received shareholder approval to exercise the option in a shareholder vote last month.

Akerna and solo sciences share a vision to protect consumers from dangerous counterfeit products, said Jessica Billingsley, chief executive officer, Akerna.

Today, more than one million solo CODEs have been sold.
Each soloCODE has a unique fingerprint, a soloTAG, for every package, augmented by the solo app, which confirms if a product is real or fake.

The technology is complementary to Akerna's MJ Platform ERP system and is driving consumer safety through its anti-counterfeiting technology and alert functionality.